Anca Berghian is an expert in Oncology at Centre Henri Becquerel (France). Anca Berghian has authored 28 publications, the most recent in 2026. SLR score: 54 (community average: 125). How the SLR is computed.

LeadR Profile

Anca Berghian Centre Henri Becquerel France
54 ScienceLeadR Reputation 54
Network Map

Oncology

Subspecialties: Dermatology - Genetics - Endocrinology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2014 - 2026

Source: PubMed

Centre Henri Becquerel

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 28

Citations

Citations: 221 1st author: 0 Last author: 0 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Characteristics and outcomes of patients with HER2-negative metastatic breast cancers with low expression of estrogen and progesterone receptors in the multicenter ESME cohort.
PMID 42160910 — estrogens, breast neoplasms, neoplasms, breast, therapeutics, receptors, progesterone, progesterone
Breast20260
Peri-Operative Detection of Circulating Tumor DNA Using a Customized NGS Tumor-Informed Assay in Patients With HPV-Negative Locally Advanced Head and Neck Squamous Cell Carcinoma.
PMID 41964148 — cells, genes, circulating tumor dna, carcinoma, squamous cell, neoplasms, squamous cell carcinoma of head and neck, dna
Int J Cancer20260
The role of body mass index at diagnosis in patients with inflammatory breast cancer.
PMID 41109066 — body mass index, breast neoplasms, neoplasms, inflammatory breast neoplasms, drug therapy, breast, obesity, diagnosis, chemotherapy
Breast20250
Prognostic value of circulating HER2 extracellular domain in patients with HER2-positive metastatic breast carcinoma treated with TDM-1 (trastuzumab emtansine).
PMID 40754555 — breast neoplasms, neoplasms, biomarkers, maytansine, ado-trastuzumab emtansine, breast, multivariate analysis, trastuzumab
Clin Transl Oncol20250
185 HMGA2::WIF1 Gene Fusion is Associated to Breast Pleomorphic Adenoma
OpenAlex W4408797818 — genes, adenoma, pleomorphic, gene fusion, breast, adenoma
Lab Invest20250

LeadR Networks

Main global connection map